Money Concepts Capital Corp Innoviva, Inc. Transaction History

Money Concepts Capital Corp

  • $1.25 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022
BUY
$11.61 - $15.22 $9,671 - $12,678
833 Added 14.72%
6,491 $75,000
Q2 2022

Jul 18, 2022
SELL
$14.32 - $19.88 $1,131 - $1,570
-79 Reduced 1.38%
5,658 $84,000
Q1 2022

May 13, 2022
BUY
$15.39 - $20.25 $88,292 - $116,174
5,737 New
5,737 $111,000

Others Institutions Holding INVA

# of Institutions
229
Shares Held
79.2M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email